Immunohistochemical analysis of biomarkers in patients with adenocarcinoma of the breast: Correlation with menopausal status and histological grade

Archives of Medical Science

Volumn 4, Issue 2, 2008, Pages 129-139

  Vinothini, Govindarajah ^a   Letchoumy, Paramasivame V ^a   Prathiba, Duvuru ^b   Nagini, Siddavaram ^a  

^a ANNAMALAI UNIVERSITY   (India)

^b SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Apoptosis; Breast cancer; Cell proliferation; Oestrogen; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; CASPASE; CYCLINE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL RECEPTOR; ESTROGEN RECEPTOR; GLUTATHIONE TRANSFERASE P1; GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROGESTERONE RECEPTOR; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; STEROID HORMONE; STEROID RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOGENESIS; CANCER PATIENT; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENOMIC INSTABILITY; HISTOPATHOLOGY; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MENOPAUSE; OXIDATIVE STRESS; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 48249146105     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hortobagyi GN, de la Garza Salazar J, Pritchard K, et al.; ABREAST Investigators. The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 2005; 6: 391-401.
2. Gopalkrishnan L, Patil S, Chhaya S, Badwe R, Joshi N. HLA alleles in pre-menopausal breast cancer patients from western India Indian J Med Res 2006; 24: 305-12.
3. Sambasivaiah K, Kumaraswamy Reddy M, Lakshmi AY, et al. Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in south India World J Surg Oncol 2007; 5: 56.
4. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006; 354: 270-82.
5. Donovan M, Tiwary CM, Axelrod D, et al. Personal care products that contain estrogens or xenoestrogens may increase breast cancer risk. Med Hypotheses 2007; 68: 756-66.
6. Zhang Y, Gaikwad NW, Olson K, Zahid M, Cavalieri EL, Rogan EG. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA. Metabolism 2006; 56: 887-94.
7. Giancotti V. Breast cancer markers. Cancer Lett 2006; 243: 145-59.
8. Liu X, Yao J, Pisha E, et al. Oxidative DNA damage induced by equine estrogen metabolites: role of estrogen receptor alpha Chem Res Toxicol 2006; 15: 512-9.
9. Nutter LM, Wu YY, Ngo EO, Sierra EE, Gutierrez PL, Abul-Hajj YJ. An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA damage. Chem Res Toxicol 1994; 7: 23-8.
10. Tsuchiya Y, Nakajima M, Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 2005; 227: 115-24.
11. Finek J, Holubec L Jr, Topolcan O, Elgrova L, Skalova A, Pecen L. The importance of prognostic factors in premenopausal women with breast cancer. Anticancer Res 2007; 27: 1893-6.
12. Malkas LH, Herbert BS, Abdel-Aziz W, et al. A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proc Natl Acad Sci USA 2006; 103:19472-7.
13. Kumaraguruparan R, Prathiba D, Nagini S. Of humans and canines: Immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours. Res Vet Sci 2006; 81: 218-24.
14. Kumaraguruparan R, Karunagaran D, Balachandran C, Manohar BM, Nagini S. Of humans and canines: A comparative evaluation of heat shock and apoptosis-associated proteins in mammary tumours. Clin Chim Acta 2006; 365: 168-76.
15. nd ed. World Health Organization, Geneva 1981.
16. Elston CW, Ellis IO. Assessment of histological grade. In: Elston CW, Ellis O, editors. The breast. Churchill Livingstone, New York, Edinburgh 1998; 356-84.
17. Ikeda K, Inoue S. Estrogen receptors and their downstream targets in cancer. Arch Histol Cytol 2004; 67: 435-42.
18. Murphy LC, Watson R Steroid receptors in human breast tumorigenesis and breast cancer progression. Biomed Pharmacother 2002; 56: 65-77.
19. Balleine R, Mote P, Hunt S, McGowan E, Clarke C. Progesterone receptors in normal and neoplastic breast. In: Ethier S (ed.) Endocrine Oncology. Humana Press, New Jersey 2000; 35-47.
20. Rossi E, Ubiali A, Cadei M, et al. HER-2/neu in breast cancer: A comparative study between histology, immunohistochemistry, and molecular technique (FISH). Appl Immunohistochem Mol Morphol 2006; 14:127-31.
21. Peiró G, Adrover E, Aranda FI, Peiró FM, Niveiro M, Sánchez-Payá J. Prognostic implications of HER-2 status in steroid receptor-positive, lymph node-negative breast carcinoma Am J Clin Pathol 2007; 127: 780-6.
22. Rashed MM, Ragab NM, Galal MK. The association of Her-2/neu overexpression in relation with p53 nuclear accumulation, hormonal receptor status and common clinicopathological prognostic parameters in a series of Egyptian women with invasive ductal carcinoma Internet J Pathol 2005; 4: 1.
23. Wilson CA, Slamon DJ. Evolving understanding of growth regulation in human breast cancer: Interactions of the steroid and peptide growth regulatory pathways. J Natl Cancer Inst 2005; 97: 1238-9.
24. Huang HJ, Neven P, Drijkoningen M, et al. Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer. J Clin Pathol 2005; 58: 611-6.
25. Haas S, Pierl C, Harth V, et al. Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas. Int J Cancer 2006; 119: 1785-91.
26. Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 2006; 5: 14.
27. Kumaraguruparan R, Kabalimoorthy J, Nagini S. Correlation of lipid peroxidation and antioxidants with clinical stage and menopausal status in patients with adenocarcinoma of the breast. Clin Biochem 2005; 38: 154-8.
28. Gago-Dominguez M, Castelao JE, Pike MC, Sevanian A, Haile RW. Lipid peroxidation and total antioxidant status in patients with breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 2829-39.
29. Matsui A, Ikeda T, Enomoto K, et al. Increased formation of oxidative DNA damage, 8-hydroxy-2′-deoxy-guanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett 2000; 151: 87-95.
30. Lacroix M, Toulon R-A, Leclercq G. p53 and breast cancer, an update. Endocr Relat Cancer 2006; 13: 293-325.
31. Huang J, Tan PH, Tan BK, Bay BH. GST-Pi expression correlates with oxidative stress and apoptosis in breast cancer. Oncol Rep 2004; 12: 921-5.
32. Biswas DK, Cruz AP, Gansberger E, Pardee AB. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci USA 2000; 97: 8542-7.
33. Maga G, Hubscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 2003; 116: 3051-60.
34. Tamatani M, Che YH, Matsuzaki H, et al. Tumour necrosis factor induces Bcl-2 and Bcl-X expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem 1999; 274: 8531-8.
35. Chandra Mohan KVP, Devaraj H, Prathiba D, Hara Y, Nagini S. Antiproliferative and apoptosis inducing effect of lactoferrin and black tea polyphenol combination on hamster buccal pouch carcinogenesis. Biochim Biophys Acta 2006; 1760: 1536-44.
36. Gupta S. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). Int J Oncol 2003; 22: 15-20.
37. Chunder N, Mandal S, Basu D, Roy A, Roychoudhury S, Panda CK. Deletion mapping of chromosome 1 in early onset and late onset breast tumours-a comparative study in eastern India Pathol Res Pract 2003; 199: 313-21.
38. Hou MF, Lin SB, Yuan SS, et al. The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer. Clin Chim Acta 2003; 334: 137-44.
39. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000; 21: 485-95.
40. Reed JC. Mechanisms of apoptosis avoidance in cancer. Curr Opin Oncol 1999; 11: 68-75.